The Biotechnology Innovation Organization (BIO) has launched a new
interactive web tool designed to help healthcare stakeholders gain a better understanding of the true facts surrounding drug costs, spending and value. More at position paper and

BIO has also produced a position paper explaining their opposition to so-called “transparency” legislation — efforts to force drug manufacturers to disclose proprietary and competitively sensitive business information … more